We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
62 hedge funds and large institutions have $159M invested in Corvus Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,029% more call options, than puts
Call options by funds: $6.07M | Put options by funds: $538K
500% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 3
216% more capital invested
Capital invested by funds: $50.2M → $159M (+$108M)
100% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 9
32% more funds holding
Funds holding: 47 → 62 (+15)
3.89% more ownership
Funds ownership: 44.11% → 48% (+3.9%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
62
Holders Change
+15
Holders Change %
+31.91%
% of All Funds
0.89%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
18
Increased
18
Reduced
9
Closed
3
Calls
$6.07M
Puts
$538K
Net Calls
+$5.54M
Net Calls Change
+$5.49M
Top Buyers
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
+$5.38M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.77M |
| 3 |
GTC
Ghost Tree Capital
New York
|
+$1.8M |
| 4 |
Goldman Sachs
New York
|
+$1.35M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.19M |
Top Sellers
| 1 |
SC
Samlyn Capital
New York
|
-$5.72M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.44M |
| 3 |
TL
TowerView LLC
New York
|
-$1.01M |
| 4 |
Renaissance Technologies
New York
|
-$637K |
| 5 |
Two Sigma Advisers
New York
|
-$187K |
